Erythropoiesis (production of red cells)
Red cells are produced continuously in the marrow of
certain bones. As stated above, in adults the principal
sites are the marrow spaces of the vertebrae, ribs,
breastbone, and pelvis.Within the bone marrow the red
cell is derived from a primitive precursor, or erythroblast,
a nucleated cell in which there is no hemoglobin. Proliferation
occurs as a result of several successive cell divisions.
During maturation hemoglobin appears in the cell, and
the nucleus becomes progressively smaller. After a few
days the cell loses its nucleus and is then introduced
into the bloodstream in the vascular channels of the
marrow. Almost 1 percent of the red cells are generated
each day, and the balance between red cell production
and the removal of aging red cells from the circulation
is precisely maintained. If blood is lost from the circulation,
the erythropoietic activity of marrow increases until
the normal number of circulating cells has been restored.
In a normal adult the red cells of about half a litre
(almost one pint) of blood are produced by the bone
marrow every week. A number of nutrient substances are
required for this process. Some nutrients are the building
blocks of which the red cells are composed. For example,
amino acids are needed in abundance for the construction
of the proteins of the red cell, in particular of hemoglobin.
Iron also is a necessary component of hemoglobin. Approximately
one-quarter of a gram of iron is needed for the production
of a pint of blood. Other substances, required in trace
amounts, are needed to catalyze the chemical reactions
by which red cells are produced. Important among these
are several vitamins, riboflavin, vitaminB12, and folic
acid, necessary for the maturation of the developing
red cell; and pyridoxine (vitamin B6), required for
the synthesis of hemoglobin. The secretions of several
endocrine glands influence red cell production. If there
is an inadequate supply of thyroid hormone, erythropoiesis
is retarded and anemia appears. The male sex hormone,
testosterone, stimulates red cell production; for this
reason, red cell counts of men are higher than those
of women.
The capacity of the bone marrow to produce red cells
is enormous. When stimulated to peak activity and when
provided adequately with nutrient substances, the marrow
can compensatefor the loss of several pints of blood
per week. Hemorrhage or accelerated destruction of red
cells leads to enhanced marrow activity. The marrow
can increase its production of red cells up to eight
times the usual rate. After that, if blood loss continues,
anemia develops. The rateof erythropoiesis is sensitive
to the oxygen tension of the arterial blood. When oxygen
tension falls, more red cells are produced and the red
cell count rises. For this reason, personswho live at
high altitude have higher red cell counts than those
who live at sea level. There is a small but significant
difference between average red cell counts of persons
living in New York City, at sea level pressure, and
persons living in Denver, Colo., one mile above sea
level, where the atmospheric pressure is lower. Natives
of the Andes, living nearly three miles above sea level,
have extremely high red cell counts.
The rate of production of erythrocytes is controlled
by a hormone (erythropoietin) that is produced largely
in the kidneys. When the number of circulating red cells
decreases or when the oxygen transported by the blood
diminishes, an unidentified sensor detects the change
and the production of erythropoietin is increased. This
substance is then transported through the plasma to
the bone marrow, where it accelerates the production
of red cells. The erythropoietin mechanism operates
like a thermostat, increasing or decreasing the rate
of red cell production in accordance with need. When
a person who has lived at high altitude moves to a sea
level environment, production of erythropoietin is suppressed,
the rate of red cell production declines, and the red
cell count falls until the normal sea level value is
achieved. With the loss of one pint of blood, the erythropoietin
mechanism is activated, red cell production is enhanced,
and within a few weeks the number of circulating red
cells has been restored to the normal value. The precision
of control is extraordinary, so that the number of new
red cells produced accurately compensates for the number
of cells lost or destroyed. Erythropoietin has been
produced in vitro (outside the body) by the technique
of genetic engineering (recombinant DNA). The purified,
recombinant hormone has promise for persons with chronic
renal failure, who develop anemia because of a lack
of erythropoietin.